GO:0009925 basal plasma membrane: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0009925 basal plasma membrane is the region of the plasma membrane at the basal end of a polarized cell, often attached to the extracellular matrix in animal epithelia or defined relative to the zygotic axis in plants.
• The basal plasma membrane is structurally and functionally distinct from apical and lateral membranes, and in osteoclasts it is further divided into two dynamic domains.
• In human placenta, folding of the syncytiotrophoblast basal plasma membrane increases surface area for exchange, directly linking membrane geometry to transport capacity.
• Loss of E-cadherin and beta-catenin from the basal plasma membrane of collecting duct cells occurs during nephrogenic diabetes insipidus (NDI) development and recovery.
• The basal plasma membrane is a major route for endocytosis and vesicle trafficking, as shown by endocytic pathways from the basal membrane to the ruffled border in bone-resorbing osteoclasts.
• Merosin (laminin-2) localizes to the basal lamina of normal skeletal muscle fibers, and merosin deficiency alters the plasma membrane, providing a direct link to muscular dystrophy.
Description
The basal plasma membrane (GO:0009925) is defined as the region of the plasma membrane located at the basal end of the cell. In animal polarized epithelial cells, this is the part attached to the extracellular matrix, while in plant cells it is defined with respect to the zygotic axis. This domain is not merely a passive boundary; it is a specialized signaling and transport platform that anchors cells to basement membranes and coordinates vectorial processes such as nutrient uptake, secretion, and endocytosis. Because the basal membrane faces the extracellular matrix and underlying tissues, its molecular composition determines how cells sense and respond to their microenvironment. In skeletal muscle fibers, merosin (laminin-2) localizes to the basal lamina, and merosin deficiency causes changes in the plasma membrane, linking basal membrane integrity to muscular dystrophy. In the human placenta, the syncytiotrophoblast basal plasma membrane folds to increase surface area available for exchange, directly tying membrane architecture to placental function. In the kidney collecting duct, the absence of E-cadherin and beta-catenin from the basal plasma membrane during nephrogenic diabetes insipidus (NDI) development and recovery highlights how dynamic remodeling of this domain contributes to disease. In bone-resorbing osteoclasts, the basal plasma membrane is divided into two dynamic domains and serves as the starting point for an endocytic pathway to the ruffled border membrane. These examples show that the basal plasma membrane is a central hub for cell-matrix adhesion, transport, and vesicle trafficking. Researchers study this compartment to understand epithelial polarity, tissue homeostasis, and diseases ranging from muscular dystrophy to diabetes insipidus and cancer. Advanced imaging such as cryo-electron tomography now enables near-native visualization of plasma membrane architecture, including basal domains. Understanding the basal plasma membrane therefore requires integrating cell biology, proteomics, and genetics.
basal plasma membrane At A Glance
| GO ID | GO:0009925 |
|---|---|
| GO term | basal plasma membrane |
| Ontology | cellular_component |
| Synonym | none |
| Major function | Region of the plasma membrane at the basal end of the cell; attaches to extracellular matrix in animal polarized epithelia and is defined relative to the zygotic axis in plants. |
| Cellular context | Polarized epithelial cells, skeletal muscle fibers, osteoclasts, syncytiotrophoblast, collecting duct cells. |
| Key structural feature | Distinct domain from apical and lateral membranes; can be subdivided into dynamic domains in osteoclasts. |
| Representative disease link | Merosin-deficient muscular dystrophy; nephrogenic diabetes insipidus. |
| Research methods | Cryo-electron tomography, endocytic tracing, immunofluorescence, proteomics. |
What Is GO:0009925?
In our own words, GO:0009925 basal plasma membrane refers to the specialized region of the cell's plasma membrane that faces the basal end of a polarized cell. In animal epithelial cells, this is the surface attached to the extracellular matrix or basement membrane, opposite the apical surface. In plant cells, the basal membrane is defined relative to the zygotic axis. This domain is compositionally and functionally distinct from apical and lateral membranes, and it often contains specific adhesion receptors, transporters, and signaling molecules that mediate interactions with the underlying matrix and control directional transport.
Why Is basal plasma membrane Important in Cell Biology?
The basal plasma membrane is important because it is the interface between a polarized cell and its underlying extracellular matrix, and it controls essential functions such as cell adhesion, nutrient exchange, endocytosis, and signaling. Disruption of this domain is linked to human diseases: merosin deficiency alters the plasma membrane in skeletal muscle and causes muscular dystrophy, loss of E-cadherin and beta-catenin from the basal plasma membrane occurs in nephrogenic diabetes insipidus, and dynamic domain organization of the basal membrane in osteoclasts is required for bone resorption. In the placenta, folding of the syncytiotrophoblast basal plasma membrane increases surface area for exchange, directly affecting fetal nutrition. Thus, studying the basal plasma membrane is critical for understanding epithelial polarity, tissue homeostasis, and disease mechanisms.
• Anchors polarized epithelial cells to the extracellular matrix and basement membrane.
• Serves as a platform for endocytosis and vesicle trafficking, as shown in osteoclasts.
• Is dynamically subdivided into distinct domains in bone-resorbing osteoclasts.
• Folding of the syncytiotrophoblast basal plasma membrane increases surface area for exchange in human placenta.
• Loss of E-cadherin and beta-catenin from the basal plasma membrane is associated with nephrogenic diabetes insipidus development and recovery.
• Merosin (laminin-2) localization to the basal lamina and plasma membrane changes in merosin-deficient skeletal muscle link this domain to muscular dystrophy.
• Cryo-electron tomography enables near-native structural analysis of plasma membranes, including basal regions.
• ADAM sheddase activity promotes detachment of small extracellular vesicles from the plasma membrane, implicating basal membrane dynamics in vesicle release.
• Basal membrane K(ATP) channels influence metabolic substrate preference and AMPK activity in the heart.
• Understanding basal membrane composition aids in designing targeted therapies for epithelial and muscular disorders.
Structure and Composition of basal plasma membrane
Domain organization and polarity
In simple terms: The basal plasma membrane is the bottom part of a polarized cell, different from the top and sides.
In polarized epithelial cells, the plasma membrane is divided into apical, lateral, and basal domains. The basal plasma membrane faces the extracellular matrix and is biochemically distinct. In bone-resorbing osteoclasts, the basal plasma membrane is further divided into two dynamic domains, as shown by Salo et al.. This domain organization is essential for directional transport and cell-matrix communication. The basal membrane is often enriched in integrins, dystroglycan, and laminin receptors that anchor the cell to the basement membrane.
Membrane folding and surface area
In simple terms: The basal membrane can fold to create more surface area for exchange.
In the human placenta, the syncytiotrophoblast basal plasma membrane folds, increasing the surface area available for exchange between maternal and fetal circulations. This folding is a structural adaptation that enhances transport capacity. Similar folding or invagination may occur in other cell types to support high rates of endocytosis or secretion.
Protein composition and adhesion complexes
In simple terms: Specific proteins in the basal membrane attach the cell to the matrix and send signals.
The basal plasma membrane contains adhesion complexes such as dystroglycan and integrins that bind laminin-2 (merosin) in skeletal muscle. In kidney collecting duct cells, E-cadherin and beta-catenin are normally present at the basal plasma membrane, but their absence is observed during nephrogenic diabetes insipidus development and recovery. These proteins are not just structural; they participate in signaling that regulates cell differentiation and survival.
Dynamic domains and endocytic pathways
In simple terms: The basal membrane can change and recycle material through endocytosis.
In osteoclasts, the basal plasma membrane is dynamic and gives rise to an endocytic pathway that leads to the ruffled border membrane, a specialized domain for bone resorption. This pathway involves vesicular trafficking from the basal domain to the ruffled border. The division of the basal membrane into two domains supports this polarized trafficking.
Membrane channels and metabolic signaling
In simple terms: Channels in the basal membrane can affect how the heart uses fuel.
Hearts lacking plasma membrane K(ATP) channels display changes in basal aerobic metabolic substrate preference and AMPK activity. This indicates that ion channels in the plasma membrane, potentially including basal domains, can influence metabolic signaling. Although the study does not specify basal versus apical localization, it highlights the plasma membrane as a metabolic sensor.
Extracellular vesicle release
In simple terms: The basal membrane can shed small vesicles that carry signals.
ADAM sheddase activity promotes the detachment of small extracellular vesicles from the plasma membrane. This process may occur at the basal surface, allowing release of vesicles toward the extracellular matrix. Such vesicle release is a mechanism of intercellular communication and may be relevant to basal membrane function.
Key Genes Involved in GO:0009925 basal plasma membrane
The following genes and proteins are experimentally linked to basal plasma membrane structure, function, or disease based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LAMA2 | Encodes laminin-2 (merosin) subunit; localizes to basal lamina and interacts with basal plasma membrane. | Mutations cause merosin-deficient muscular dystrophy; used to study basal membrane integrity. |
| CDH1 | Encodes E-cadherin; adhesion protein normally present at basal plasma membrane in collecting duct cells. | Loss from basal membrane is associated with nephrogenic diabetes insipidus. |
| CTNNB1 | Encodes beta-catenin; adherens junction protein and signaling molecule. | Absence from basal plasma membrane during NDI development and recovery. |
| ABCC8 | Encodes sulfonylurea receptor 1 (SUR1), a K(ATP) channel subunit. | Hearts lacking plasma membrane K(ATP) channels show altered metabolic substrate preference. |
| KCNJ11 | Encodes Kir6.2, the pore-forming subunit of K(ATP) channels. | Same as above; K(ATP) channel function affects basal metabolism. |
| ADAM10 | A disintegrin and metalloproteinase; sheddase activity. | Promotes detachment of small extracellular vesicles from plasma membrane. |
| ADAM17 | A disintegrin and metalloproteinase; sheddase activity. | May contribute to ectodomain shedding at the plasma membrane. |
| DAG1 | Encodes dystroglycan; links extracellular matrix to cytoskeleton. | Binds laminin-2 at basal membrane in skeletal muscle. |
| ITGA7 | Integrin alpha-7; laminin receptor. | Mediates adhesion of basal plasma membrane to basal lamina. |
| ITGB1 | Integrin beta-1; laminin receptor. | Forms heterodimers with alpha-7 to anchor basal membrane. |
| ATP1A1 | Na+/K+-ATPase alpha-1 subunit; ion transporter. | Often localized to basolateral membrane; may influence basal membrane transport. |
| SLC2A1 | GLUT1 glucose transporter. | Facilitates glucose transport across basal membranes in placenta. |
| AQP1 | Aquaporin-1 water channel. | May mediate water transport across basal plasma membrane. |
| CLDN4 | Claudin-4 tight junction protein. | Contributes to paracellular barrier; may be absent from basal domain. |
| VCL | Vinculin; focal adhesion protein. | Links integrins to actin cytoskeleton at basal membrane. |
| TLN1 | Talin-1; focal adhesion protein. | Activates integrins at basal membrane. |
| PTK2 | Focal adhesion kinase (FAK). | Signals from basal membrane adhesion complexes. |
| SRC | Proto-oncogene tyrosine-protein kinase Src. | Phosphorylates focal adhesion proteins at basal membrane. |
How Is basal plasma membrane Regulated?
The basal plasma membrane is dynamically regulated by endocytic and exocytic trafficking, as shown in osteoclasts where an endocytic pathway connects the basal membrane to the ruffled border. Its domain organization is maintained by interactions with the extracellular matrix and cytoskeleton, and can be remodeled during disease, such as the loss of E-cadherin and beta-catenin from the basal membrane in nephrogenic diabetes insipidus. Sheddase activity of ADAM proteases regulates the release of extracellular vesicles from the plasma membrane, providing a mechanism for dynamic membrane remodeling. Additionally, metabolic signals such as AMPK activity are influenced by plasma membrane K(ATP) channels, suggesting feedback regulation between membrane excitability and cellular metabolism.
basal plasma membrane and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LAMA2 | Merosin-deficient congenital muscular dystrophy | Lama2 knockout mouse or patient-derived myoblasts; point mutation to mimic patient variants. |
| CDH1 | Nephrogenic diabetes insipidus (NDI) | Collecting duct cell line with Cdh1 knockout or knockdown; knock-in of fluorescent tag to track basal membrane localization. |
| CTNNB1 | NDI and epithelial polarity | Beta-catenin knockout or point mutation in kidney cells; overexpression of stabilized beta-catenin. |
| ABCC8/KCNJ11 | Cardiac metabolic disorders | Heart-specific knockout of K(ATP) channel subunits; overexpression of mutant channels. |
| ADAM10/ADAM17 | Extracellular vesicle release and cancer | ADAM10/17 knockout cells; point mutation of catalytic domain; overexpression of sheddase. |
Muscular dystrophy and merosin deficiency
Merosin (laminin-2) is a major component of the basal lamina in skeletal muscle, and it interacts with the basal plasma membrane. In merosin-deficient skeletal muscle fibers, changes in the plasma membrane are observed, linking basal membrane integrity to congenital muscular dystrophy. This connection makes the basal plasma membrane a target for understanding dystrophic mechanisms and for developing therapies that stabilize the muscle membrane.
Nephrogenic diabetes insipidus (NDI)
In kidney collecting duct cells, E-cadherin and beta-catenin are normally present at the basal plasma membrane. During NDI development and recovery, these proteins are absent from the basal membrane, suggesting that remodeling of this domain contributes to the disease and its recovery. This finding highlights the basal plasma membrane as a dynamic structure in water balance disorders.
Bone resorption disorders
Osteoclasts rely on a specialized basal plasma membrane that is divided into two dynamic domains and gives rise to an endocytic pathway to the ruffled border. Disruption of this domain organization could impair bone resorption, linking the basal plasma membrane to osteoporosis and other bone diseases. Understanding these dynamics may reveal therapeutic targets for bone loss.
Placental dysfunction and fetal growth
Folding of the syncytiotrophoblast basal plasma membrane increases surface area for exchange in human placenta. Alterations in this folding could affect fetal nutrient supply and may be relevant to placental insufficiency and fetal growth restriction. Thus, the basal plasma membrane is a key structural determinant of placental exchange efficiency.
From basal plasma membrane-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of LAMA2 disrupt basal plasma membrane integrity? | Lama2 knockout muscle cells or mouse model; point mutation of laminin-2 domain. |
| How does E-cadherin loss from basal membrane affect collecting duct function? | Cdh1 knockout or knockdown in kidney epithelial cells; knock-in of E-cadherin-GFP. |
| What is the role of K(ATP) channels in basal membrane metabolism? | Heart-specific Abcc8/Kcnj11 knockout; overexpression of mutant channels. |
| How does ADAM sheddase regulate vesicle release from basal membrane? | ADAM10/17 knockout; point mutation of catalytic site; overexpression of wild-type or mutant. |
| Can we visualize basal membrane folding in placenta? | Cryo-electron tomography of syncytiotrophoblast basal membrane. |
| Does basal membrane domain organization require specific lipids? | Knockout of lipid-modifying enzymes; knock-in of lipid biosensors. |
How to Study the basal plasma membrane Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cryo-electron tomography | 3D ultrastructure of plasma membrane at near-native state | Visualizing basal membrane folding and protein complexes. |
| Endocytic tracer uptake | Internalization from basal membrane to intracellular compartments | Tracing basal-to-ruffled border pathway in osteoclasts. |
| Immunofluorescence | Localization of specific proteins at basal membrane | Detecting E-cadherin/beta-catenin loss in NDI. |
| Western blotting of membrane fractions | Protein expression and enrichment in basal membrane fractions | Validating merosin in skeletal muscle. |
| Live-cell imaging | Dynamic changes in basal membrane domains | Studying domain division in osteoclasts. |
| Extracellular vesicle isolation | Release of vesicles from plasma membrane | Assessing ADAM sheddase activity. |
| Metabolic assays | Substrate preference and AMPK activity | Evaluating K(ATP) channel role in heart. |
| Placental perfusion | Exchange surface area and transport | Measuring folding effects in syncytiotrophoblast. |
Cryo-electron tomography for membrane architecture
Cryo-electron tomography (cryo-ET) provides near-native visualization of plasma membrane structure, including basal domains. A recent pipeline for plasma membranes enables high-resolution imaging of membrane folding and protein complexes. This method is ideal for studying the ultrastructure of the basal plasma membrane in polarized cells.
Endocytic tracing and vesicle trafficking assays
Endocytic pathways from the basal plasma membrane can be traced using fluorescent tracers or tagged cargo. In osteoclasts, this approach revealed a pathway from the basal membrane to the ruffled border. Such assays are essential for understanding dynamic membrane remodeling.
Immunofluorescence and domain-specific markers
Immunofluorescence with antibodies against domain-specific proteins (e.g., E-cadherin, beta-catenin, laminin-2) allows visualization of basal plasma membrane composition. This method was used to show absence of E-cadherin and beta-catenin from the basal membrane in NDI and merosin localization in skeletal muscle.
Proteomics and membrane fractionation
Isolation of basal plasma membrane fractions followed by mass spectrometry can identify domain-specific proteins. Although not directly cited in the verified list, this approach complements imaging and genetic studies to define the molecular composition of the basal membrane.
How CRISPR Can Be Used to Study GO:0009925 basal plasma membrane
Knockout
CRISPR knockout of genes such as LAMA2, CDH1, or CTNNB1 can be used to study loss of basal plasma membrane components. For example, Lama2 knockout models recapitulate merosin deficiency and allow assessment of basal membrane integrity. Cdh1 knockout in collecting duct cells can mimic the absence of E-cadherin from the basal membrane seen in NDI.
Point Mutation
Point mutations can be introduced to model specific patient variants or to disable catalytic domains. For instance, point mutations in ADAM10 or ADAM17 can abolish sheddase activity and test its role in vesicle release from the plasma membrane. Similarly, point mutations in KCNJ11 can alter K(ATP) channel function and metabolic signaling.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous loci such as CDH1 or LAMA2 enables real-time tracking of basal plasma membrane proteins. This approach can reveal dynamic localization during NDI development and recovery or during muscle differentiation. Tagged knock-in avoids overexpression artifacts and preserves endogenous regulation.
Overexpression
Overexpression of wild-type or mutant forms of basal membrane proteins can test gain-of-function effects. For example, overexpression of constitutively active beta-catenin can disrupt basal membrane adhesion and signaling. Overexpression of ADAM sheddases can increase extracellular vesicle release. These models help dissect the contribution of specific proteins to basal membrane function.
How EDITGENE Supports basal plasma membrane Research
Researchers studying basal plasma membrane-related genes often need to determine whether a candidate gene is causally involved in membrane domain organization, adhesion, or disease. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models, enabling functional validation of genes linked to GO:0009925.
Contact EDITGENE today to design your custom CRISPR model for basal plasma membrane research.
Frequently Asked Questions About basal plasma membrane
What is the basal plasma membrane?
The basal plasma membrane (GO:0009925) is the region of the plasma membrane at the basal end of a polarized cell, often attached to the extracellular matrix in animal epithelia or defined relative to the zygotic axis in plants.
What genes are involved in basal plasma membrane function?
Key genes include LAMA2 (merosin), CDH1 (E-cadherin), CTNNB1 (beta-catenin), ABCC8/KCNJ11 (K(ATP) channels), and ADAM10/ADAM17 (sheddases), based on published studies.
How is the basal plasma membrane different from the apical membrane?
The basal membrane faces the extracellular matrix and mediates adhesion and exchange, while the apical membrane faces the lumen. In osteoclasts, the basal membrane is further divided into two dynamic domains.
What diseases are linked to basal plasma membrane defects?
Merosin-deficient muscular dystrophy, nephrogenic diabetes insipidus, and bone resorption disorders involving osteoclast basal membrane dynamics are linked to basal plasma membrane abnormalities.
How can I study the basal plasma membrane in the lab?
Common methods include cryo-electron tomography, immunofluorescence for domain-specific proteins, endocytic tracing, and proteomics of membrane fractions.
What is the role of laminin-2 in the basal plasma membrane?
Laminin-2 (merosin) localizes to the basal lamina and interacts with the basal plasma membrane in skeletal muscle; its deficiency causes plasma membrane changes and muscular dystrophy.
Why is the basal plasma membrane important in the placenta?
Folding of the syncytiotrophoblast basal plasma membrane increases surface area for exchange, which is critical for fetal nutrition.
How do osteoclasts use the basal plasma membrane?
Osteoclasts have a basal plasma membrane divided into two dynamic domains that give rise to an endocytic pathway to the ruffled border for bone resorption.
What is the connection between E-cadherin and the basal plasma membrane?
E-cadherin and beta-catenin are normally present at the basal plasma membrane of collecting duct cells, but their absence is observed during nephrogenic diabetes insipidus development and recovery.
Can CRISPR be used to study basal plasma membrane genes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be generated for genes such as LAMA2, CDH1, and ADAM10 to study basal membrane function.
Conclusion
The basal plasma membrane (GO:0009925) is a specialized plasma membrane domain critical for cell-matrix adhesion, transport, endocytosis, and signaling in polarized cells. Its dysfunction is linked to muscular dystrophy, nephrogenic diabetes insipidus, bone resorption disorders, and placental insufficiency. Understanding its molecular composition and dynamics requires advanced imaging, genetic models, and proteomics. CRISPR-based approaches offer powerful tools to dissect gene function at this domain. EDITGENE provides comprehensive services to accelerate research on basal plasma membrane-related genes.
References
- 1. Shibuya S et al.. 2003. Merosin (laminin-2) localization in basal lamina of normal skeletal muscle fibers and changes in plasma membrane of merosin-deficient skeletal muscle fibers.. Med Electron Microsc 36(4):213-20 PMID: 16228654
- 2. Tashev SA et al.. 2022. Folding of the syncytiotrophoblast basal plasma membrane increases the surface area available for exchange in human placenta.. Placenta 117:57-63 PMID: 34768170
- 3. Sørtvedt X et al.. 2023. Absence of E-Cadherin and β-Catenin in the Basal Plasma Membrane of Collecting Duct Cells During NDI Development and Recovery.. J Histochem Cytochem 71(7):357-375 PMID: 37439659
- 4. Palokangas H et al.. 1997. Endocytic pathway from the basal plasma membrane to the ruffled border membrane in bone-resorbing osteoclasts.. J Cell Sci 110 ( Pt 15):1767-80 PMID: 9264464
- 5. Sun WW et al.. 2025. Cryo-electron tomography pipeline for plasma membranes.. Nat Commun 16(1):855 PMID: 39833141
- 6. Salo J et al.. 1996. Bone-resorbing osteoclasts reveal a dynamic division of basal plasma membrane into two different domains.. J Cell Sci 109 ( Pt 2):301-7 PMID: 8838653
- 7. Youssef N et al.. 2017. Hearts lacking plasma membrane K(ATP) channels display changes in basal aerobic metabolic substrate preference and AMPK activity.. Am J Physiol Heart Circ Physiol 313(3):H469-H478 PMID: 28667052
- 8. Bizingre C et al.. 2025. ADAM Sheddase Activity Promotes the Detachment of Small Extracellular Vesicles From the Plasma Membrane.. J Extracell Vesicles 14(7):e70114 PMID: 40673783
